Compound class:
Synthetic organic
Comment: The chemical structure for envudeucitinib was obtained from proposed INN list 130 (Feb. 2024), in which the compound is described as a Janus kinase inhibitor with anti-inflammatory potential.
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
N-[4-[2-methoxy-3-[1-(trideuteriomethyl)-1,2,4-triazol-3-yl]anilino]-5-(3,3,3-trideuteriopropanoyl)pyridin-2-yl]cyclopropanecarboxamide |
International Nonproprietary Names | |
INN number | INN |
12803 | envudeucitinib |
Database Links | |
CAS Registry No. | 2417135-66-9 (source: WHO INN record) |
GtoPdb PubChem SID | 491299987 |
PubChem CID | 158715582 |
Search Google for chemical match using the InChIKey | FKCATCQHVCOBCX-WFGJKAKNSA-N |
Search Google for chemicals with the same backbone | FKCATCQHVCOBCX |
Search PubMed clinical trials | envudeucitinib |
Search PubMed titles | envudeucitinib |
Search PubMed titles/abstracts | envudeucitinib |
UniChem Compound Search for chemical match using the InChIKey | FKCATCQHVCOBCX-WFGJKAKNSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | FKCATCQHVCOBCX-WFGJKAKNSA-N |